Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens

BACKGROUND: Cancer-associated neoantigens (neoAg) derived from tumor genomic sequencing and predictive algorithms for mutated peptides are a promising basis for therapeutic vaccines under investigation. Although these are generally designed to bind major histocompatibility complex class I and induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekri, Selma, Rodney-Sandy, Reunet, Gruenstein, Diana, Mei, Anna, Bogen, Bjarne, Castle, John, Levey, Daniel, Cho, Hearn Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862454/
https://www.ncbi.nlm.nih.gov/pubmed/35190376
http://dx.doi.org/10.1136/jitc-2021-003572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862454/
https://www.ncbi.nlm.nih.gov/pubmed/35190376
http://dx.doi.org/10.1136/jitc-2021-003572

Ejemplares similares